Longitudinal Assessment of Traumatic Microvascular Injury-2
Part of paid clinical trials in Philadelphia, Pennsylvania.
- Sponsor
- University of Pennsylvania
- Study ID
- NCT05725993
- Status
- Recruiting
Conditions
- Traumatic Brain Injury
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 65 Years
- Healthy Volunteers
- Accepted
Study Details
The goal of this observational study is to learn about changes in the brain of patients over the first 3 years following a traumatic brain injury (TBI). The main question it aims to answer are: \- How TBI effect the rate of brain tissue loss compare to healthy brain Participants will give blood samples, complete MRI scans, and neuropsychological assessment measures. Researchers will compare results between healthy control group and TBI group to determine changes in injured brains.
Key Dates
- Start date
- Feb 1, 2022
- Status verified
- Mar 2026
- Primary completion
- Mar 1, 2027
- Completion
- Mar 1, 2027
Study Design
- Enrollment
- 110 participants (estimated)
Arms
- Arm: TBI Patient
- Arm: Healthy Control
Primary Outcome Measure
Brain Atrophy [ Time Frame: 3 years ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Pennsylvania | Philadelphia | Pennsylvania | 19041 |
Find similar trials in Philadelphia, PA
By research site
Related Studies
- Mobile Health Self-Management and Support System for Chronic and Complex Health ConditionsRecruiting · University of Pittsburgh · Pittsburgh, Pennsylvania
- University of Pittsburgh Brain Health InitiativeRecruiting · David Okonkwo, MD, PhD · Pittsburgh, Pennsylvania
- Inhaled Nitric Oxide for Microvascular Dysfunction in Traumatic Brain InjuryPHASE2 · Enrolling By Invitation · University of Pennsylvania · Philadelphia, Pennsylvania
- Sildenafil for Microvasculopathy in Chronic TBIPHASE2 · Recruiting · University of Pennsylvania · Philadelphia, Pennsylvania